• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Merus Labs International Inc

+ Add to Watchlist

MSLI:US

1.9886 USD 0.0214 1.06%

As of 20:10:00 ET on 09/12/2014.

Snapshot for Merus Labs International Inc (MSLI)

Open: 2.0200 Day's Range: 1.9600 - 2.0300 Volume: 12,496
Previous Close: 2.0100 52wk Range: 0.9901 - 2.5900 1-Yr Rtn: +94.96%

Stock Chart for MSLI

No chart data available.
  • MSLI:US 1.9886
  • 1D
  • 1M
  • 1Y
2.0100
Interactive MSLI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MSLI

Current P/E Ratio (ttm) -
Estimated P/E(09/2012) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (09/2012) -
Est. PEG Ratio -
Market Cap (M USD) 148.29
Shares Outstanding (M) 74.57
30 Day Average Volume 21,457
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MSLI

No data available

Company Profile & Key Executives for MSLI

Merus Labs International, Inc. is a pharmaceutical company. The Company acquires and licenses niche branded pharmaceutical products in the United States and Canada. Merus's products include anti-infectives and wound care products.

David D Guebert "Dave"ChairmanElie K FarahPresident/CEO
Andrew P PatientChief Financial OfficerAli MoghaddamVP:Bus Dev & Commercial Ops
More Company Profile & Key Executives for MSLI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil